Glaukos Corporation
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro…
Medical - Devices
US, San Clemente [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 3 | $2,000,000 | LD-2 : 10/17/24 |
| 2024 | 2 | $3,000,000 | LD-2 : 07/20/24 |
| 2024 | 2 | $2,000,000 | LD-2 : 07/15/24 |
| 2024 | 1 | $2,000,000 | LD-2 : 04/17/24 |
| 2023 | 4 | $2,000,000 | LD-2 : 01/18/24 |
Get PRO Today
With PRO you will unlock 1 more lobbying disclosures for Glaukos Corporation